Vanguard Personalized Indexing Management’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$233K	Sell	1,695 -251	-13%	-$34.5K	﹤0.01%	1555
2025 Q1	$351K	Buy	1,946 +546	+39%	+$98.4K	0.01%	1272
2024 Q4	$219K	Sell	1,400 -138	-9%	-$21.6K	﹤0.01%	1486
2024 Q3	$280K	Buy	1,538 +164	+12%	+$29.9K	﹤0.01%	1375
2024 Q2	$252K	Buy	+1,374	New	+$252K	﹤0.01%	1345